ALB and Hypoalbuminemia: As comorbid conditions, diabetes, chronic lung disease, and hypoalbuminemia (Alb < 3.0 g/dL) at the initiation of JAKis were 25 (18.8%), 30 (22.6%), and 25/124 (20.2%) patients, respectively.